Bob Temple is giving up his post as acting director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research and will be replaced by Ellis Unger, the office's deputy director. The change will allow Temple to devote more time to his duties as deputy director for clinical science, according to CDER Director Janet Woodcock.

Full Story:

Related Summaries